Search hospitals

>

Colorado

>

Aurora

University of Colorado Cancer Center

Claim this profile

Aurora, Colorado 80045

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Cancer

Conducts research for Pancreatic Cancer

Conducts research for Melanoma

675 reported clinical trials

27 medical researchers

Photo of University of Colorado Cancer Center in AuroraPhoto of University of Colorado Cancer Center in AuroraPhoto of University of Colorado Cancer Center in Aurora

Summary

University of Colorado Cancer Center is a medical facility located in Aurora, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Pancreatic Cancer, Melanoma and other specialties. University of Colorado Cancer Center is involved with conducting 675 clinical trials across 466 conditions. There are 27 research doctors associated with this hospital, such as Bradley R. Corr, Jessica D. McDermott, Theresa M. Medina, and Jose M. Pacheco.

Area of expertise

1

Lung Cancer

Global Leader

University of Colorado Cancer Center has run 102 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
HER2 positive
Stage III
2

Breast Cancer

Global Leader

University of Colorado Cancer Center has run 101 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 positive
Stage III

Top PIs

Clinical Trials running at University of Colorado Cancer Center

Breast Cancer

Lung Cancer

Pancreatic Cancer

Cancer

Ovarian Cancer

Colorectal Cancer

Melanoma

Solid Tumors

Endometrial Cancer

Non-Small Cell Lung Cancer

Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

Imlunestrant

for Early Breast Cancer

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

STX-478 + Fulvestrant

for Advanced Breast Cancer

This trial is testing a new drug called STX-478 to see if it can help treat advanced solid tumors and breast cancer. The study will look at how safe the drug is, how it behaves in the body, and if it can stop or slow down cancer growth. Some patients will receive just STX-478, while others will get it combined with another drug called fulvestrant, which is often used to treat advanced breast cancer.

Recruiting

1 award

Phase 1 & 2

5 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Colorado Cancer Center?

Where is University of Colorado Cancer Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Colorado Cancer Center accept?

What awards or recognition has University of Colorado Cancer Center received?